United Therapeutics Corporation (UTHR)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqGSUnited StatesUS91307C1027
593.31 USD
-0.39% today Updated 12 Nov 2026 21:02
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by United Therapeutics Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:02. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
24 Feb 2027
in 103 days · 08:00 · estimate 4.46
Last results
5.71 vs 6.04 estimated
04 Nov 2026 · Miss -5.5%
Beat the estimate
6 of 12
5 missed · 1 in line
Average surprise
-1.1%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 24 Feb 2027 08:00 | 4.46 | — | — | Upcoming |
| 04 Nov 2026 06:00 | 6.04 | 5.71 | -5.5% | Miss |
| 05 Aug 2026 06:00 | 6.86 | 7.27 | +6.0% | Beat |
| 06 May 2026 06:00 | 6.86 | 5.82 | -15.1% | Miss |
| 25 Feb 2026 06:00 | 6.76 | 7.70 | +14.0% | Beat |
| 29 Oct 2025 06:00 | 6.96 | 7.16 | +2.9% | Beat |
| 30 Jul 2025 06:00 | 7.30 | 6.41 | -12.2% | Miss |
| 30 Apr 2025 06:00 | 6.54 | 6.63 | +1.3% | Beat |
| 26 Feb 2025 06:00 | 6.84 | 6.19 | -9.5% | Miss |
| 30 Oct 2024 06:00 | 7.12 | 7.07 | -0.7% | In line |
| 31 Jul 2024 06:00 | 6.41 | 5.85 | -8.7% | Miss |
| 01 May 2024 06:00 | 5.59 | 6.17 | +10.3% | Beat |
| 21 Feb 2024 06:00 | 4.19 | 4.36 | +4.2% | Beat |
| 01 Nov 2023 06:00 | 5.04 | 5.38 | +6.7% | Beat |
| 02 Aug 2023 06:00 | 4.78 | 5.24 | +9.5% | Beat |
| 03 May 2023 06:00 | 4.71 | 4.86 | +3.2% | Beat |
| 22 Feb 2023 06:00 | 5.21 | 3.64 | -30.0% | Miss |
| 02 Nov 2022 06:00 | 3.77 | 4.91 | +30.3% | Beat |
| 03 Aug 2022 06:00 | 4.54 | 3.46 | -23.8% | Miss |
| 04 May 2022 06:00 | 3.07 | 5.03 | +63.8% | Beat |
| 24 Feb 2022 06:00 | 4.05 | 3.51 | -13.3% | Miss |
| 03 Nov 2021 06:00 | 3.58 | 3.42 | -4.5% | Miss |
| 04 Aug 2021 06:00 | 3.56 | 4.09 | +14.7% | Beat |
| 05 May 2021 06:00 | 3.49 | 3.49 | +0.0% | In line |
| 24 Feb 2021 06:00 | 3.51 | 3.31 | -5.6% | Miss |
| 28 Oct 2020 06:00 | 3.34 | 3.88 | +16.1% | Beat |
| 29 Jul 2020 06:00 | 3.28 | 3.68 | +12.4% | Beat |
| 29 Apr 2020 06:00 | 3.39 | 3.61 | +6.6% | Beat |
| 26 Feb 2020 06:00 | 2.51 | 1.20 | -52.2% | Miss |
| 30 Oct 2019 06:00 | 2.90 | 3.83 | +32.2% | Beat |
| 31 Jul 2019 06:00 | 2.74 | 3.63 | +32.6% | Beat |
| 01 May 2019 06:00 | 2.77 | -11.32 | -509.2% | Miss |
| 27 Feb 2019 06:00 | 2.55 | 3.34 | +30.9% | Beat |
| 31 Oct 2018 06:00 | 3.03 | 2.42 | -20.1% | Miss |
| 01 Aug 2018 06:00 | 3.42 | 4.36 | +27.3% | Beat |
| 02 May 2018 06:00 | 4.00 | 3.76 | -6.0% | Miss |
| 21 Feb 2018 06:00 | 4.58 | 3.89 | -15.0% | Miss |
| 25 Oct 2017 06:00 | 4.80 | 4.69 | -2.4% | Miss |
| 27 Jul 2017 06:00 | 3.66 | 4.37 | +19.4% | Beat |
| 26 Apr 2017 06:00 | 3.82 | 3.61 | -5.6% | Miss |
| 22 Feb 2017 06:00 | 3.80 | 4.12 | +8.4% | Beat |
| 27 Oct 2016 06:00 | 3.79 | 4.36 | +15.2% | Beat |
| 28 Jul 2016 06:00 | 3.16 | 4.39 | +39.0% | Beat |
| 28 Apr 2016 06:00 | 3.16 | 3.02 | -4.5% | Miss |
| 25 Feb 2016 06:00 | 2.59 | 2.10 | -18.9% | Miss |
| 27 Oct 2015 06:00 | 3.39 | 9.24 | +172.6% | Beat |
| 28 Jul 2015 06:00 | 2.31 | 1.91 | -17.5% | Miss |
| 28 Apr 2015 06:00 | 2.13 | -0.36 | -116.9% | Miss |
| 24 Feb 2015 06:00 | 2.02 | 2.17 | +7.5% | Beat |
| 28 Oct 2014 06:00 | 1.93 | -0.53 | -127.5% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 3.2B | +10.6% | 1.3B | 41.9% | 27.86 | +13.1% | 1B |
| 2024 | 2.9B | +23.6% | 1.2B | 41.5% | 24.64 | +24.4% | 1.1B |
| 2023 | 2.3B | +20.2% | 984.8M | 42.3% | 19.81 | +32.1% | 747.6M |
| 2022 | 1.9B | — | 727.3M | 37.6% | 15.00 | — | 663.7M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 570.47 | 598.80 | 556.63 | 593.31 | +5.57% | 1,720,030 | |
| 02 Nov 2026 – 06 Nov 2026 | 596.54 | 614.23 | 559.41 | 562.02 | -6.13% | 3,066,200 | |
| 26 Oct 2026 – 30 Oct 2026 | 589.11 | 609.99 | 581.88 | 598.72 | +1.91% | 2,344,600 | |
| 19 Oct 2026 – 23 Oct 2026 | 539.10 | 590.98 | 534.61 | 587.50 | +10.20% | 2,927,000 | |
| 12 Oct 2026 – 16 Oct 2026 | 553.49 | 555.59 | 523.95 | 533.12 | -2.92% | 3,475,100 | |
| 05 Oct 2026 – 09 Oct 2026 | 540.41 | 558.30 | 524.79 | 549.16 | +1.38% | 5,065,700 | |
| 28 Sep 2026 – 02 Oct 2026 | 473.84 | 585.79 | 470.76 | 541.70 | +13.93% | 7,214,200 | |
| 21 Sep 2026 – 25 Sep 2026 | 497.70 | 500.05 | 468.97 | 475.45 | -3.88% | 3,263,400 | |
| 14 Sep 2026 – 18 Sep 2026 | 506.78 | 509.07 | 492.57 | 494.63 | -0.50% | 5,654,000 | |
| 08 Sep 2026 – 11 Sep 2026 | 494.74 | 509.79 | 479.71 | 497.11 | +1.95% | 2,370,200 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- What iShares S&P Mid-Cap 400 Growth ETF (IJK) Bought: FTI Leads on Tuesday (opens in a new tab) GuruFocus.com · 12 Nov 2026 11:05
- iShares Core S&P Mid-Cap (IJH) Adds TechnipFMC and United Therapeutics on Tuesday (opens in a new tab) GuruFocus.com · 12 Nov 2026 11:04
- Liquidia Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 10 Nov 2026 18:15
- United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences (opens in a new tab) 09 Nov 2026 12:00
- HC Wainwright & Co. Assumes United Therapeutics at Buy, Announces Price Target of $660 (opens in a new tab) Benzinga · 09 Nov 2026 07:19
- The 5 most interesting analyst questions from United Therapeutics’s Q3 2026 earnings call (opens in a new tab) StockStory · 08 Nov 2026 22:37
- SPDR S&P MidCap 400 ETF (MDY) Adds Glaukos and United Therapeutics on Wednesday (opens in a new tab) GuruFocus.com · 06 Nov 2026 11:04
- United Therapeutics (UTHR) Stock May Be Undervalued After $2B Buyback Plan (opens in a new tab) Simply Wall St. · 05 Nov 2026 17:13
- TD Cowen Maintains Buy on United Therapeutics, Raises Price Target to $700 (opens in a new tab) Benzinga · 05 Nov 2026 16:39
- RBC Capital Maintains Outperform on United Therapeutics, Raises Price Target to $725 (opens in a new tab) Benzinga · 05 Nov 2026 16:05
- Wells Fargo Maintains Overweight on United Therapeutics, Raises Price Target to $703 (opens in a new tab) Benzinga · 05 Nov 2026 11:21
- Should Record Revenue Require Action From United Therapeutics Stock Investors? (opens in a new tab) Simply Wall St. · 05 Nov 2026 11:10
- What Is Drawing Attention To United Therapeutics (UTHR) Today? (opens in a new tab) Simply Wall St. · 05 Nov 2026 03:12
- United Therapeutics Corporation Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 04 Nov 2026 23:05
- What United Therapeutics (UTHR) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 04 Nov 2026 22:14
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 595.66 USD
- Market cap
- 25.3B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow UTHR and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.